News
Trump ends the de minimis exemption, halting duty-free imports globally. Chinese e-commerce giants like Shein and Temu face ...
57m
YouTube on MSNA UNIQUE IDEA FOR YOURSELF FOR WELDERS FROM STOCK MATERIALS
Welcome to my channel Mr Sagoo where you will learn how to make handmade crafts, presents, toys, and life hacks. The main ...
The three high-profile Republicans gunning for longtime U.S. Sen. Mitch McConnell’s seat gathered under one roof this weekend ...
1h
The Manila Times on MSNInvestors to focus on inflation, GDP
SECOND-QUARTER growth data, July inflation and further developments in US trade policy will likely drive market sentiment ...
On July 28, President Donald Trump’s attorneys filed an urgent motion in federal court demanding the expedited deposition of ...
On “This Week,” ABC News’ chief Washington correspondent Jonathan Karl reports on Trump’s latest tariffs, weak jobs report ...
2h
Investor's Business Daily on MSNDow Jones Futures: What To Do After Market Sell-Off. Palantir, AMD Lead Big Earnings.
The stock market sold off Friday on Trump tariffs and a bad jobs report. Here's what to do. Palantir, AMD headline another ...
2h
Cryptopolitan on MSNGulf stocks drop as poor earnings and U.S. tariffs shake investor confidence
Stocks in the Gulf dropped Sunday as investors responded to poor earnings and fresh economic pressure from the United States, ...
At issue is the Trump administration's use of the International Economic Emergency Powers Act (IEEPA) to impose tariffs. The Court of Appeals heard from the Trump administration's lawyer last week ...
OPEC+ agreed on Sunday to raise oil production by 547,000 barrels per day for September, the latest in a series of ...
4h
India Today on MSNHow Trump tariffs could impact Indian pharma's $8.7 bn dream run
Indian pharma companies will need to change tack and find newer markets should the Trump administration impose a reciprocal tariff on pharma imports ...
AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results